Home
Kynam Capital Management reported a 4.33% stake in Cogent Biosciences COGT · 6,165,223 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 4.33%
- Last report
- 5.54% · filed 25/11/14
- Shares held
- 6,165,223 sh
- Class
- Common Stock, par value $0.001
- Holder
- Kynam Capital Management
- Event date
- 25/12/31
- Filed
- 26/02/17
4.33% stake · below 5%
- Stake
- 4.33%
- Last report
- 5.54%
- Since last report
- −1.2pp
Cogent Biosciences trades, last 26 weeks
What else happened in Cogent Biosciences around then
Filed or reported within 30 days of the trade day · 25/12/01~01/30Kynam Capital Management's other 5% stake reports
- Kynam Capital Management
5% stakeViridian Therapeutics, Inc.\DE
5% stakeViridian Therapeutics, Inc.\DE
VRDN
5.7% stake
0 sh
5.7% stake
Filed 08/14
- Kynam Capital Management
5% stakeVera Therapeutics
5% stakeVera Therapeutics
VERA
4.01% stake
0 sh
4.01% stake
Filed 08/14
- Kynam Capital Management
5% stakeCytomX Therapeutics
5% stakeCytomX Therapeutics
CTMX
9.96% stake
0 sh
9.96% stake
Filed 08/14
- Kynam Capital Management
5% stakeCelldex Therapeutics
5% stakeCelldex Therapeutics
CLDX
6.78% stake
0 sh
6.78% stake
Filed 08/14
- Kynam Capital Management
5% stakeBurning Rock Biotech
5% stakeBurning Rock Biotech
BNR
13.97% stake
0 sh
13.97% stake
Filed 05/15
